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Abstract 
Background: Widespread usage of contraceptive pills and Medroxyprogesterone acetate (Depo-Provera) as an 
injectable contraceptive can affect various biochemical and physiological factors, such as lipid profiles, fasting blood 
sugar (FBS) and systolic and diastolic blood pressure. The purpose of this study was to determine the relationship 
between the use of oral contraceptives, medroxyprogesterone acetate and natural birth control methods with 
biochemical and physiological markers. Materials and Methods: In this study, the serum samples of all subjects 
(200 women taking depo-Provera, 200 taking contraceptive pills and 200 women who had natural birth control) were 
collected. Then fast blood sugar, lipid profiles, systolic and diastolic blood pressure, and BMI were measured and 
recorded. Results: There was no significant difference between the mean and standard deviation of FBS and HDL 
between the three examined groups, but there were significant differences in lipid profiles biomarkers, blood pressure 
and BMI among three groups. Indeed, mean TG, LDL, cholesterol, BMI and systolic and diastolic blood pressure 
showed significant higher levels in contraceptive pills users compared to other groups. Also, in the users of depot-
medroxyprogesterone acetate, the mean of TG, LDL, cholesterol, BMI and systolic blood pressure was significantly 
higher than the natural birth control users. There was a significant difference between the three groups in terms of 
the duration of the contraceptive method usage, which indicated that the depot-medroxyprogesterone acetate was 
utilized for a long period of time in compared to other methods. In addition, contraceptive pills users were more 
likely to suffer from headache and nausea, and depot-medroxyprogesterone acetate users experienced changes in 
their menstrual cycle, such as spotting. Conclusion: It seems that oral contraceptive has no significant relationship 
with serum HDL level, and cholesterol is more affected by contraceptive drugs.  
Keywords: Medroxyprogesterone acetate (Depo-Provera), Oral contraceptive pills, Menstrual Cycle, Biochemical 
Factors, Physiological Factors. 
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Introduction 
Over-population is one of the most serious 
problems around the world, so various contraceptive 
methods are used to control unintended pregnancies 
[1]. Among these procedures, Oral contraceptive pills 
have been widely used as an effective method[2]. 
Recently, approximately 25% of women aged 15-44 
uses the LD, Low Dose, as contraception. Generally, 
there are three types of oral contraceptives: 1) 
Estrogen-progesterone combination; 2) Progesterone 
3) take contraceptive pill without a break[3]. 
Currently, various studies have been shown 
that the side effects of oral contraceptives are not 
severe and will disappear by changing to another type. 
The most common side effects of oral contraceptives 
listed as headache, nausea, pain, breast tenderness, 
painful proximity, spotting (changes in the menstrual 
period), hair loss, abdominal cramps and excessive 
vaginal discharge or decreased libido[4-7]. Other 
surveys have shown that taking contraceptive pills will 
have a significant effects on the metabolism of lipids, 
carbohydrates, as well as the blood pressure[8, 9]. In 
this regards, a report indicated that the levels of 
triglyceride, cholesterol, HDL, and LDL-C had 
significant increased levels in contraceptives pill 
users[10], while in another study, the level of LDL-c 
did not show the significant statistical differences 
among contraceptive pills users versus those who did 
not take these medication[11]. 
Medroxyprogesterone acetate, as a 
contraceptive drug, is a weak androgenic 
progesterone (injected intramuscularly every three 
months) which inhibits the gonadotropin activity[12]. 
However, women taking this contraceptive drug may 
have some side effects such as dysregulation in 
menstrual cycle, weight changes, headache, anxiety, 
abdominal pain, dizziness and weakness or 
fatigue[13]. Although a large number of researches 
have been conducted to evaluate the   
medroxyprogesterone acetate relationships with lipid 
profile, but, the results are not consistent in various 
studies[14, 15]. 
 A study showed that in the 
medroxyprogesterone acetate users, cholesterol, 
LDL-C, VLDL, triglyceride and fasting blood 
glucose (FBS) levels were significantly increased in 
compared to untreated group, while HDL levels 
decreased[16]. In addition, blood sugar and insulin 
levels have been increased in medroxyprogesterone 
acetate users versus oral contraceptive pills users[17]. 
Other contraceptive methods include the use 
of natural birth control methods such as the condoms 
usage. It has been reported that the use of intrauterine 
devices reduces the frequency of sexual intercourse 
and sexual satisfaction due to increased irregular 
bleeding[18, 19]. There are few reports about the 
effects of using natural birth control methods on serum 
levels of biochemical markers, such as cholesterol, 
triglycerides and blood sugar. In addition, there are few 
studies which investigate the impacts of these 
contraceptive methods on clinical factors such as 
changing the menstrual cycle and hair loss. Therefore, 
studying the relationship between this contraceptive 
procedures and physiological and biochemical markers 
can be useful. Although several studies have been 
performed to investigate the possible relationships 
between taking oral contraceptives and using 
medroxyprogesterone acetate with lipid profiles, blood 
sugar, blood pressure, BMI as well as side effects such 
as headache, nausea, pain and chest sensation, painful 
sexual intercourse, spotting (changes in the 
menstruation cycle) and hair loss, but there are 
numerous inconsistencies in the results of these 
surveys. Hence, in this study, we examined the precise 
relationships between these variables. 
 
Methods 
A prospective study (descriptive-analytical 
type) were conducted with 600 subjects as the 
population study comprising the 200 women using 
medroxyprogesterone acetate, 200 taking oral 
contraceptives, and 200 who had Natural birth control. 
All of the research units were located in the areas 
covered by the Neka Health Center. The non-pregnant 
subject’s age was range between 20 and 41 years. Also, 
in the past few months, all women didn’t use any other 
contraception except for medroxyprogesterone acetate, 
combined contraceptive pills and natural birth control. 
Likewise, subjects had regular menstrual cycle and did 
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not complain about the studied complications, such as 
headache, back pain and etc . 
The blood samples were drawn and serum 
separated. Then the serum levels of FBS, cholesterol, 
triglyceride and HDL-c using Pars Azmun kits (Iran) 
were measured. Iran. Also the LDL-c were calculated 
by the Friedewald equation. Systolic and diastolic 
blood pressure and BMI of the all subjects were also 
assessed and recorded. All participants were asked to 
complete a questionnaire including these age, number 
of children, type of contraception, history of using 
contraceptive method, headache, nausea, pain and 
chest sensitivity, painful sexual intercourse, marital 
satisfaction, spotting (dysregulation in menstrual 
cycle), hair loss, demographic status, the history of any 
disease in studied women and their family (diabetes, 
blood pressure, any chronic disease, history of abortion 
or high risk delivery).  Then data accurately recorded. 
statistical analysis was performed using SPSS 18 
software. The SMIRNOV-KOLMOGOROV test was 
used to assess the normal distribution of data. Then the 
data were analyzed by INDEPENDENT SAMPLE 
TEST, FISHER EXACT TEST, ONEWAY ANOVA, 
POST HOC TUKEY, and Chi-Square tests. P≤0.05 
was considered as a significant level. 
 
Results 
The mean age in the depot-
medroxyprogesterone acetate users group was 31.78 ± 
5.5, in the users of contraceptive pills was 32.67 ± 4.8 
and in the Natural birth control users  group was 31.91 
± 5.35. As presented in Table 1, there were no 
significant differences in the mean age between three 
groups (Table 1). Depot-medroxyprogesterone acetate 
users (three months) had a higher number of children 
in compared to other groups. (P = 0.000) (Table 1). 
There was a significant difference between the 
three groups in total duration of contraceptive use 
which indicated that depot-medroxyprogesterone 
acetate had longer use of this method (Table 1). 
In evaluating the side effects, the results 
revealed that, contraceptive pills users were more 
likely to suffer from headache and nausea, and depot-
medroxyprogesterone acetate users experienced 
dysregulation in menstrual cycle, such as spotting. 
There is no statistically significant difference in other 
complications between the groups (Table 2).  
As presented in Table1, the statistical 
significant differences in biochemical and clinical 
parameters including lipid profiles, systolic & diastolic 
blood pressure and BMI between three groups were 
presented. But there are any significant differences in 
FBS and HDL-c levels among studied groups (Table 
1). Table 3 shows the in-paired comparison of lipid 
profile, FBS, blood pressure and BMI between groups. 
As shown in Table 3, the mean levels of TG, LDL, 
cholesterol, BMI, systolic & diastolic blood pressure 
show a significant increase in contraceptive pill users 
compared to the other two groups. Also, the Mean 
levels of TG, LDL, cholesterol, BMI and systolic blood 
pressure were significantly higher in the depot-
medroxyprogesterone acetate users in compared to 
natural birth control users. Although there were 
statistically significant differences in levels of 
cholesterol, triglyceride, LDL and blood pressure, but 
the values were within the normal range. 
Table1. The mean and standard deviation of lipid profiles, FBS, blood 
pressure and BMI in three groups including; depot-medroxyprogesterone 
















0.19 31.78±5.5 32.67±4.8 31.91±5.35 Age, years 
0.0001 2.2±0.8 1.98±0.61 1.74±0.68 
Number of 
Children 
0.9 88.3±11.9 88.68±10.5 88.17±12.3 FBS, mg/dL 
0.0001 133.1±48.75 144.4±46.7 121.2±57.1 TG, mg/dL 
0.0001 169.3±35 187.2±21.9 153.9±37.3 CHOL, mg/dL 
0.0001 96.1±36.5 111.6±24.17 81.29±39 LDL-C, mg/dL 
0.2 46.56±11.4 46.75±11.15 48.4±12.9 
HDL-C, 
mg/dL 
0.02 66.52±7.23 68.47±7.7 66.67±8.9 DBP, mmHg 




0.0001 27.04±3.7 28.15±3.7 25.19±3.3 BMI,  kg/m2 
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Table 2. Side effects distribution in the depot-medroxyprogesterone acetate and contraceptive pills users. 




% with group 
99(49.5%) 101(50.5%) 200(100%) 
DEPO. 
Count 
% with group 
175(87.5%) 25(12.5%) 200(100%) 
P-Value 0.0001 --- 




% with group 
123(61.5%) 77(38.5%) 200(100%) 
DEPO. 
Count 
% with group 150(75%) 50(25%) 200(100%) 
P-Value 0.005 --- 




% with group 
177(88.5%) 23(11.5%) 200(100%) 
DEPO. 
Count 
% with group 174(87%) 26(13%) 200(100%) 
P-Value 0.76 --- 




% with group 
133(66.5%) 67(33.5%) 200(100%) 
DEPO. 
Count 
% with group 140(70%) 60(30%) 200(100%) 
P-Value 0.51 --- 




% with group 
67(33.7%) 132(66.3%) 200(100%) 
DEPO. 
Count 
% with group 61(30.5%) 139(69.5%) 200(100%) 
P-Value 0.52 --- 




% with group 
181(90.5%) 19(9.5%) 200(100%) 
DEPO. 
Count 
% with group 151(75.5%) 49(24.5%) 200(100%) 
P-Value 0.0001 --- 




% with group 
136(68%) 64(32%) 200(100%) 
DEPO. 
Count 
% with group 147(73.5%) 53(26.5%) 200(100%) 
P-Value 0.27 --- 
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Discussion 
Uncontrolled pregnancy is one of the most 
important challenges of the century. Recently, various 
pharmaceutical and physical procedures are now used 
as contraceptive methods, which each procedures is 
accompanied with many challenges and 
complications[20, 21].  
In this regards, several side effects such as 
headache, nausea, pain and breast tenderness, painful 
sexual intercourse, spotting (menstrual cycle 
dysregulation), and hair loss have been reported[22]. 
Therefore, numerous studies have been conducted to 
evaluate the lipid profiles, blood sugar and other 
relevant biochemical indices to further explore the risk 
of using contraceptives. On the other hand, the use of 
natural birth control methods such as condoms reduces 
sexual satisfaction and increases the risk of vaginal 
infections and unwanted pregnancy[23, 24]. 
Therefore, the replacement of natural birth 
control methods with drug based methods can 
overcome these challenges. At the same time, careful 
evaluations of the contraceptives effects on individual 
health are required. Due to need for accurate evaluation 
of contraceptive drugs side effects, we aimed to study 
 
Table 3. In paired comparison of variables in three examined groups: depot-medroxyprogesterone acetate, contraceptive pills and natural 






Std. Error Sig. 






Natural L.D. -0.75 0.52 0.15 -1.78 0.27 
Natural DEPO. 0.13 0.52 0.79 -0.89 1.16 
L.D. DEPO.  0.89 0.52 0.09 -0.14 1.92 
Number of 
Children 
Natural L.D. -0.23 0.07 0.001 -0.37 -0.09 
Natural DEPO. -0.48 0.07 0.000 -0.62 -0.34 
L.D. DEPO.  -0.24 0.07 0.001 -0.38 -0.1 
FBS, mg/dL 
Natural L.D. -0.5 1.16 0.66 -2.78 1.77  
Natural DEPO. -0.12 1.16 0.91 -2.4 2.15 
L.D. DEPO.  0.38 1.16 0.74 -1.9 2.66 
TG, mg/dL 
Natural L.D. -23.18 5.11 0.000 -33.21 -13.14 
Natural DEPO. -11.88 5.11 0.02 -21.91 -1.84 
L.D. DEPO.  11.3 5.11 0.027 1.26 21.33 
CHOL, mg/dL 
Natural L.D. -33.26 3.21 0.000 -39.5 -26.94 
Natural DEPO. -15.39 3.21 0.000 -21.7 -9.07 
L.D. DEPO.  17.87 3.21 0.000 11.55 24.18 
LDL-C, mg/dL 
Natural L.D. -30.29 3.38 0.000 -36.95 -23.64 
Natural DEPO. -14.87 3.38 0.000 -21.53 -8.22 
L.D. DEPO.  15.42 3.38 0.000 8.76 22.07 
HDL-C, mg/dL 
Natural L.D.  1.67 1.18 0.15 -0.65 4 
Natural DEPO. 1.86 1.18 0.11 -0.46 4.19 
L.D. DEPO.  0.19 1.18 0.87 -2.14 2.52 
DBP, mmHg 
Natural L.D. -1.8 0.79 0.025 -3.36 -0.23 
Natural DEPO. 0.15 0.79 0.85 -1.41 1.71 
L.D. DEPO.  1.95 0.79 0.01 0.38 3.51 
SBP, mmHg 
Natural L.D. -2.63 1.13 0.021 -4.85 -0.4 
Natural DEPO. 2.5 1.13 0.028 0.27 4.72 
L.D. DEPO.  5.13 1.13 0.000 2.9 7.35 
BMI,  kg/m2 
Natural L.D. -2.96 0.36 0.000 -3.66 -2.25 
Natural DEPO. -1.84 0.36 0.000 -2.55 -1.14 
L.D. DEPO.  1.11 0.36 0.002 0.4 1.82 
Usage history, 
years 
Natural L.D. 0.32 0.24 0.18 -0.15 0.8 
Natural DEPO. 1.29 0.24 0.000 0.81 1.77 
L.D. DEPO.  0.97 0.24 0.000 0.49 1.45 
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the biochemical biomarkers such as FBS, cholesterol, 
triglyceride, HDL, and LDL.  
The results of our study emphasized that 
nevertheless the contraceptives effects on lipid profile 
(despite its significant impacts) these methods could be 
a good alternative to natural methods. However, in 
some high-risk groups (such as cardiovascular patients 
and people with lipid metabolism disorders), it should 
be prescribed and administered more precisely. 
The results of this study showed that there is 
no significant relationship between different 
contraceptive methods (depot-medroxyprogesterone 
acetate, contraceptive pills and natural birth control 
users) in fast blood sugar level (Table 1). Therefore, it 
could be proposed that carbohydrate metabolic 
pathways do not affected by pregnancy medications.  
Therefore, it could be suggested that the 
individual’s situations which are predispose to 
metabolic carbohydrate diseases (including diabetes), 
is not decisive in determining the methods of 
contraception. In this regards, Beasley et al. (2012) did 
not show a significant correlation between serum FBS 
levels and oral contraceptive use[25]. 
Our study showed that (based on the 
contraceptive methods type), among the measured 
lipid profile bio markers, the greatest effects were 
exerted on the levels of triglycerides, cholesterol and 
LDL. So that, LD use increases the mean of all three 
mentioned lipid parameters. Likewise, Fadlalmola et 
al, in 2019 showed that oral contraceptive use has a 
significant relationship with serum cholesterol levels 
in the studied subjects[26]. A study by Muhsin et al 
(2019) in Samarra, Iraq, confirmed the association of 
contraceptive use with a significant increase in lipid 
profiles[27]. 
The use of depot-medroxyprogesterone 
acetate increases the mean of studied biomarkers. But, 
the amounts of increase were less than that of 
contraceptive pill users. With all the above, it can be 
concluded that taking contraceptive drugs interferes 
with lipid metabolism pathways. On the other hand, the 
average increase in lipid profile biomarkers is within 
the normal range. So, it is not necessary to remove the 
contraceptive drug from the treatment cycle (in terms 
of changing the risk of atherosclerotic complications).  
However, it is suggested that contraceptive drugs 
should be used with caution in disorders of Lipid 
Metabolism, as well as those at risk for heart disease 
and atherosclerotic individuals. In addition, our 
findings which show the significant relationship 
between the contraception pathway with systolic and 
diastolic blood pressure and BMI confirmed this 
important issue.  
A study by Beasley et al. (2012) also found 
that there were significant relationships between serum 
LDL levels and oral contraceptives use. Though 
Khatun et al.  research in 2019 was not in accordance 
with our results. In this study, which was conducted in 
Dhaka, Bangladesh (in the long-term follow-up), there 
was no significant statistical relationship between 
contraceptive use and lipid profile increase[28].  
Conclusion 
In summary, according to the results of 
presented survey, oral contraceptive use has no 
significant relationship with serum HDL level, so, it 
could be suggested that cholesterol (the most different 
lipid factor in terms of placement in LDL and HDL 
lipoprotein structure) more affected by contraceptive 
drugs. Considering the significant relationship 
between contraception method and most measured 
variables, it could be suggested that the further studies 
should be designed and continued to examine other 
important biochemical indices. In addition, long-term 
follow-up can reflect a more reliable situation in 
assessing the effects of contraceptive methods on 
individual health 
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